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Introduction
Malaria, caused by mosquito-borne hematoprotozoan parasites of the genus Plasmodium, is endemic in more than 90 countries, and together with HIV and tuberculosis constitutes one of the major causes of death by infectious diseases worldwide. 1, 2 The WHO estimates that worldwide, 300-500 million clinical cases of malaria occur annually, with sub-Saharan Africa accounting for more than 90%. Mortality due to malaria is estimated to be over 1 million deaths each year. The vast majority of deaths occur among young children in Africa, especially in remote rural areas with poor access to health services. 2 Major contributing factors to the severity of this disease are the widespread emergence of chloroquine/ mefloquine resistance in P. falciparum as well as resistance to insecticides in the Anopheles vector. 3 In addition, efforts to develop effective anti-malarial vaccines have remained largely unsuccessful, despite major research efforts worldwide. 1, 3 A better understanding of the natural mechanisms of host defense against the Plasmodium parasite may provide new targets for therapeutic intervention 26 November 2001 in this disease. Such mechanisms may manifest themselves as genetic determinants of susceptibility to infection in endemic areas of disease and during epidemics. 
Genetic factors in susceptibility to malaria in humans
A large body of evidence has accumulated over the past 50 years to indicate that genetic factors can influence the onset, progression, severity of disease, and ultimate outcome of malaria infection in man. This genetic component is complex, multigenic, and its analysis by genetic epidemiology, linkage and association studies, as well as by candidate genes testing has revealed important threeway interactions between host genes, environment, and the malarial parasite (for comprehensive reviews, please see references 5-7). For example, important ethnic differences in disease severity have been reported in endemic areas of West Africa, 8 and segregation analyses have indicated a genetic component in the control of malaria infection. [9] [10] [11] Linkages analyses in Burkina Faso have suggested a complex genetic component of susceptibility with levels of parasitemia linked to 5q31-q33. 12 In addition, segregation analyses in Papua New Guinea have suggested that response to parasite load in the form of antibody production and lymphocyte proliferation is genetically controlled. 13 Independent studies have also pointed at an important genetic control of host immune responses to malaria. 14, 15 Finally, twin studies in The Gambia showed that susceptibility to malaria-induced fever has a heritable component linked to the MHC. 16, 17 Malaria is unique, as normal or disease-associated alterations in certain erythrocyte proteins affect susceptibility to infection in humans, with possible positive selec-tion of these variants by the parasite in endemic areas. The Duffy antigen encodes a chemokine receptor (DARC) expressed on red blood cells (RBC), and recognized by the parasite. A variant polymorphism at a GATA-1 binding site in the promoter of the DARC gene affects protein expression on erythrocytes and therefore modulates parasite entry into RBC and susceptibility to infection. 18 In sickle-cell anemia, heterozygosity for mutant hemoglobin alleles confers survival advantage over homozygosity for either mutant or wild type alleles. [19] [20] [21] [22] Likewise, a protective effect against malaria has been associated with ␣ and ␤ thalassemias [23] [24] [25] and glucose-6-phosphate dehydrogenase deficiencies. 26, 27 Finally, population-based association studies have detected several proteins that may play an important role in parasite invasion and host response to malaria. Promotor polymorphisms in the tumor necrosis factor ␣ (TNF␣) gene have been associated with malaria susceptibility. 28 Homozygosity at TNF-308A was found associated with increased risk of cerebral malaria in Gambian and Kenyan children, 29 while a second polymorphism (TNF-238A) also showed association to severe anaemia in the Gambian patients. 30 A TNF-376A polymorphism appears to recruit the transcription factor OCT-1 to the promotor, resulting in increasing gene expression in monocytes, and increased susceptibility to infection. 31 Both positive and negative results have been published for association of severe malaria with polymorphisms in the gene for one of the nitric oxide synthase isoforms, and the parasite endothelial receptor intercellular adhesion molecule-1 (ICAM). 6 Therefore, the study of genetic determinants of susceptibility to malaria in humans has started to provide important information on proteins playing a key role in parasite pathogenesis and host immune response to malaria.
A mouse model of malaria infection
The genetic component of susceptibility to malaria is acknowledged to be complex in humans. 4 In addition, reduced penetrance, variable expressivity, a wide disease spectrum associated with variations in parasite-encoded virulence determinants, together with poor diagnostic criteria make it very difficult to decipher and map single gene effects, even if major, in human populations. Complex genetic traits can, however, be dissected in genetically well-defined inbred, recombinant inbred, and recombinant congenic strains of mice in which single gene effects may have either naturally segregated or have been experimentally isolated by breeding. These genes can then be localized in linkage studies, and in certain cases, can be identified by transcription mapping and positional cloning. [32] [33] [34] [35] [36] The mouse is the experimental model of choice for this type of analysis for the following reasons: (1) the virulence status of the infectious agent, as well as the dose, and route of infection can be tightly controlled, thereby reducing microbial-induced variability; (2) large numbers of wild-type isolates and mutant stocks of mice are available in an inbred status; (3) informative segregating animals can be generated in large numbers for linkage mapping and positional cloning; (4) the sequence of the mouse genome is soon to be completed, providing a compendium of candidate genes for a particular region; (5) null alleles at candidate genes can be readily obtained by gene targeting; and (6) 37, 38 The symptoms and pathology associated with blood-stage infection of mice with P. chabaudi , while not exactly mirroring those associated with human malaria, are similar enough that murine models have been useful in defining the immunological basis of some of the pathology in man (reviewed in Mohan and Stevenson 5 ). Many blood-stage antigens of this parasite are analogous to those of P. falciparum. 38 Both reticulocytes and mature red cells are invaded in immunodeficient hosts during severe P. chabaudi AS infection. 39 There is suppression of both T and B cell responses during blood-stage infection. 40, 41 P. chabaudi AS undergoes sequestration, although in the spleen and liver and not in the brain, as does the human parasite. 42 Finally, infection of inbred mouse strains with this parasite results in non-lethal or lethal infections, dependent upon the genetic background of the host. 43, 44 In this infection model, a rapid proliferation of the parasite during the first 6-8 days is followed by a curative phase, with inflammatory, immune and erythropoietic responses resulting in elimination of the parasites by days 21-28 in 'resistant' animals. In susceptible mice, parasite replication continues unabated, ultimately leading to uniform death in this group by days 10-13. Expression of resistance, including recovery from infection requires intact T cell, and macrophage function, and is eliminated by splenectomy prior to infection. 45, 46 Studies in nude mice, 46 and SCID mice 47 as well as CD4 + T cell-depleted mice 39, 48 have established a key role for CD4 + T cells in resistance to infection. More recent studies in mouse mutants bearing null mutations at various genes have established that granulocyte-macrophage colony-stimulating factor, 49 ␥-interferon, 50 TNF␣, 51 IL-12 (Su and Stevenson, unpublished observations), and the SR-A scavenger receptor 52 are required for resistance to infection.
Strain variations in susceptibility
When infected with strains of P. chabaudi, inbred mouse lines show different degrees of susceptibility, as measured by either the extent of blood-stage parasite replication or overall mortality (Table 1 ). An early survey of mice infected intraperitoneally with 10 6 parasitized RBC (P. chabaudi AS) using survival as an indicator of suscepti- Fortin et al (1997), 55 c Foote et al (1997). 53 bility, segregated inbred strains into either resistant (CBA, C57BL/6, C57L, DBA/2) or susceptible (A/J, BALB/c, AKR, DBA/1, C3H/HeJ, SJL). 44 Susceptibility was generally associated with higher parasitemia (129/Sv, A/J; 55-75% of infected RBC vs C57BL/6, DBA/2; 20-45%) at the peak of infection. 44 Using a different P. chabaudi sub-strain (P. chabaudi adami DS), and a different infection protocol (10 4 or 10 5 , intravenously), Foote et al (1997) 53 also reported the susceptibility of C3H/HeJ, and SJL (65-75% average peak parasitemia, 100% mortality) and resistance of C57BL/6J (40% average peak parasitemia, Ͻ5% mortality). Interestingly, F1 hybrids between resistant and susceptible strains (A/J X C57BL/6; SJL X C57BL/6) are more resistant to infection by both criteria, indicating that resistance may be dominant over susceptibility, and suggesting further complementation of additional parental susceptibility loci in the hybrid. Finally, male mice are more susceptible than females with respect of peak parasitemia and survival. 44, 54, 55 Genetic studies were undertaken to analyze the complexity and to map individual genes responsible for interstrain differences in susceptibility to mouse malaria infection. Following intraperitoneal (i.p.) infection with a dose of 10 6 P. chabaudi AS parasitized RBC, resistant C57BL/6 mice exhibit a course of infection characterized by a mean peak parasitemia of about 25% parasitized RBC, followed by decreasing parasitemia and elimination of primary infection by 4 weeks ( Figure 1 ). These hosts experience a moderate level of anemia coincident with eight to 10-fold increase in spleen weight and exuberant splenic erythropoiesis. 56 In contrast, susceptible A/J strain mice experience severe anemia, minimal splenomegaly (three to four-fold normal) and develop a fulminant parasitemia with a mean peak greater than 45% parasitized RBC, with death occurring between days 10 to 13 post infection ( Figure 1 ). This strain exhibits a defect in the amplification of splenic erythropoiesis, and shows reduced reticulocytosis after phenylhydrazine-induced anemia when compared to C57BL/6. 44, 56 A study of the early development of Th cell subsets in A/J and C57BL/6 mice indicated that early in infection, activation of CD4 + Th1 cells with production of high levels of IFN-␥, occurred in the spleen of C57BL/6, while induction of a Th2 response, with production of IL-4, IL-5 and IL-10, was seen in A/J mice. 57, 58 Parallel experiments showed that treatment of A/J mice with IL-12 (stimulation of IFN-␥ production) significantly decreased parasitemia, increased splenic erythropoiesis and reduced mortality following infection. 59, 60 Studies in resistant C57BL/6 and IL-12-treated A/J mice identified a requirement for CD4 + T cells, IFN-␥ and TNF-␣ for control and resolution of P. chabaudi AS infection. 39, 46, 47, 58, 59, 61 The marked inter-strain difference in susceptibility to P. chabaudi infection suggested that a genetic approach may identify key host defense mechanisms against this infection.
Studies in recombinant inbred strains
To initiate the search for P. chabaudi AS susceptibility loci responsible for the inter-strain difference of A/J (A) and C57BL/6 (B6) mice, a panel of 16 recombinant inbred (RI) strains derived from A and B6 parents (AXB/BXA) were phenotyped for P. chabaudi AS susceptibility. RI strains are useful mapping tools for single gene effects. They are produced by continuous inbreeding (n Ͼ20 generations) of F2 animals, resulting in individual strains showing fixed chimeric chromosomes with distinct combinations of parental haplotypes. Each AXB/BXA strain contains a 50:50 ratio of genome from A and B6. 62 Because RI strains have been genotyped and phenotyped for many markers and traits, the concordance of strain distribution patterns (SDP) between a novel trait (such as P. chabaudi AS susceptibility) and the SDP of a mapped genetic or phenotypic marker can be used to map single gene effects. On the other hand, the absence of bi-modal SDP for a specific trait may be suggestive of a multigenic control. Two to five mice from AXB/BXA strains were infected with P. chabaudi AS and parasitemia was followed daily. Three types of responses were noted with respect to peak parasitemia and mortality (Figure 2a) . Certain strains behaved like B6, with low peak parasitemia (20-40%), and no mortality (AXB-6, and 8; BXA-26, 16, and 17), while others behaved like A with high parasitemia (50-70%), and high mortality (AXB-15, BXA-25, AXB -19, 18, 20) . A third group (BXA-2, 11, AXB-24, BXA-24, 7, and 4) showed intermediate peak parasitemia levels (40-50%). This suggests that genetic control of peak parasitemia is complex and is not determined by a single locus. Although showing similar peak parasitemia values, certain strains in this latter group showed marked differences in mortality rates (Figure 2a ; compare BXA-2 and 11 with BXA-4, and 7), further suggesting that some of the genetic determinants affecting mortality may have segregated from those controlling blood parasitemia in these strains. Together, these results are consistent with the proposal that multiple genes contribute to susceptibility to P. chabaudi AS infection in A and B6. Comparison of the SDP of AXB/BXA for susceptibility to infection with the SDP of a bank of 200 genetic markers typed in these strains suggested several candidate regions for susceptibility, but none reached statistical significance. 
Genetic linkage studies in backcross and F2 mice
To map loci controlling peak parasitemia in A and B6 mice, 263 (AXB) F1XA backcross mice was bred and typed for susceptibility to P. chabaudi AS infection, using 10 6 parasitized RBC injected by the i.p. route. 55 Peak parasitemia values in this backcross showed a continuous distribution and therefore behaved as a quantitative trait amenable to QTL analysis (Figure 3a) . A whole genome scan was carried out in a subset of these mice (47 resistant, 47 susceptible) which showed extreme peak parasitemia values (see legend, Figure 3a) . Following genetic analysis, suggestive linkages to Chr. 8 and 5 were identified, with weaker linkages to Chr. 15 and 17. Subsequent studies in additional P. chabaudi AS-infected (AXB)F2 mice also selected for extreme phenotypes strengthened the Chr. 8 linkage (Figure 3b) , while other QTLs fell . 55 The chromosome 8 locus was estimated to account for 10% of the phenotypic variance in these crosses. Independently, Foote et al (1997) , 53 conducted similar linkage analyses in female mice from informative (SJL X C57BL/6)F2 and (C3H/HeJ X C57BL/6)F2 infected intravenously with 10 4 or 10 5 RBC parasitized with P. chabaudi adami DS. Peak parasitemia and mortality were used as phenotypic markers for whole genome scans. Linkage to death was detected to Chr. 9 (LOD = 11.5) and to Chr. 8 (LOD = 5.95) in the C3H cross. Linkage to peak parasitemia was found on Chr. 9 in both C3H and SJL crosses (LOD = 6.6; LOD = 9.1, respectively), and to Chr. 8 in the C3H cross (LOD = 8.83). Therefore, these studies identified at least two loci on Chr. 9, and Chr. 8 controlling susceptibility to infection which were given the appellation Char1, and Char2 (for Chabaudi resistance), respectively (Table 2) . Finally, a linkage to the H-2 locus on Chr. 17 (LOD = 5.0) was noted the day following the peak of parasitemia (day 11) in P. chabaudi adami DS-infected (C3H X C57BL/6)F2 female animals, and was given the name Char3 (Table  2) . 63 Visual inspection of the peak parasitemia data obtained for AXB/BXA RI strains and comparison with their Chr. 8 haplotypes, suggested a contribution of Char2 alleles (Chr. 8). Indeed, 8/8 strains with highest peak parasitemia values but only 4/8 strains showing lower values inherited A alleles at Char2 (Figure 2b ). In addition, RI strains showing A haplotypes for both Char1 and Char2 were the most susceptible as measured by peak parasitemia and survival (Figure 2b) .
The genetic interval for Char2 on Chr. 8 contains interesting candidates, including several erythrocyte structural proteins such as glycophorin A, the erythrocyte antigen 1 locus (Ea1), and erythrocyte protein 1 (Erp1), as well as the cytokine IL-15, and the class A scavenger receptor (SR-AI/SR-AII). Interestingly, a null mutation at the SR-A locus causes susceptibility to bacterial (Listeria monocytogenes) and viral (HSV-1) infections, 64 and shows a modest effect on susceptibility to P. berghei infection. 52 In addition, the sequence of SR-A from A and B6 shows a cluster of non-conservative substitutions in the extracellular portion of the protein which alter three-dimentional conformation of the receptor, including recognition by specific antibodies. 65, 66 However, major functional consequences of these polymorphisms on SR-A remain to be demonstrated. The Chr. 9 interval of Char1 contains several candidates 53 with possible function in RBC physiology, including transferrin (Trf), haptoglobin (Hp), as well as two retinol binding proteins (RBP-1, 2) . A possible association of these proteins with susceptibility to malaria has yet to be formally tested.
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Studies in recombinant congenic strains
Recombinant congenic strains of mice (RCS) contain a small amount (12.5%) of DNA from one parent fixed as a set of discrete congenic segments, on the background (87.5%) of DNA from the other parent. 67 These strains offer a unique opportunity to analyze multigenic traits, as individual resistance/susceptibility loci may independently segregate in individual RCS. They can also be used to characterize the specific phenotypic component of disease susceptibility under genetic control. The relatively small size of the congenic segments fixed in individual RCS also facilitates the search and testing of candidate genes mapped in individual strains. A novel set of AcB/BcA recombinant congenic strains, derived from A and B6 parents was recently described. 68 These strains were produced by systematic inbreeding pairs of [(AXB)XA]XA (AcB) and of [(AXB)XB]XB (BcA) double backcross mice (N3) to generate a set of 15 AcB and 22 BcA strains. Genotyping of these strains for 625 markers (average spacing 2.6 cM) indicated that in the AcB set, (a) individual strains contain on average 13.25% of B6 resistant genome, and (b) that 79% of the total B6 resistant genome had been transferred in independent strains of the AcB series. 68 Our group recently used AcB strains to map novel malaria resistance loci derived from B6, and fixed by inbreeding on the susceptible background of A. Male and female mice from 13 AcB and five BcA strains were infected with P. chabaudi AS, and peak parasitemia and mortality were used to establish susceptibility/resistance ( Figure 4 ). As expected from their A background, 8/13 AcB strains were clearly susceptible (AcB-53, 62, 54, 51, 65, 56, 60, and 58; high peak parasitemia, high mortality). Three of 13 strains (AcB-64, 57, 52) showed intermediate phenotypes, with peak parasitemia between A and C57BL/6 control values and limited mortality more pronounced in males (Figure 4) . Finally, 2/13 strains (AcB-61, 55) were clearly resistant with low parasitemia, and low mortality. As anticipated from their resistant B6 background, the five BcA strains tested were found to be either resistant (BcA-81, 78) or intermediate (BcA-82, 69, 71) with none susceptible (Figure 4) . The haplotype combination of these strains for the Char1 (Chr. 9) and Char2 (Chr. 8) was examined in relation to their resistance/susceptibility phenotype. In the AcB set (Figure 4) , all strains showed A susceptible haplotypes at Char1. In addition, the Char2 alleles appeared to influence susceptibility in the AcB set: 7/8 susceptible strains had susceptible A alleles, while 3/3 AcB strains showing intermediate phenotypes had B6 alleles.
Resistance in AcB61 and AcB55 was not associated with B6 haplotypes at Char2 (Figure 4) . Analysis of the course of blood parasitemia during infection (Figure 1) shows rapid parasite replication in AcB55 and AcB61 mice during the first 6 days of infection, with initial rates similar to those seen in A and B6 controls. Interestingly, in AcB55 mice, peak parasitemia occurs at days 7-8, one to two days earlier than resistant B6 controls (days 9-10), followed by a curative phase of parasite clearance which occurs at a rate similar to that seen in B6 (Figure 1) . These results suggest segregation of new resistance locus or loci in AcB55 within one or several of the few B6 chromosomal segments fixed in this strain, and which is (are) phenotypically expressed as early onset of inhibition of parasite replication and rapid parasite clearance following peak parasitemia. 69 Therefore, a search for such loci was undertaken in informative (AcB55 X A)F2, and (AcB61 X A)F2 mice, using peak parasitemia as a phenotypic quantitative trait (Figures 5 and 6 ), and by a limited genome scan procedure using markers informative for the B6 congenic segments of the two RC strains. Linkage analysis in the AcB61 F2 cross failed to detect significant linkage with any of the B6 segments segregating in the cross. Possible explanations for this apparent lack of linkage include (a) multiple small additive or epistatic B6-encoded gene effects, or (b) a new mutation on A background of that strain, or (c) presence of small but relevant B6 congenic segments in AcB61 that may have gone undetected in the characterization of the strain. Linkage studies in (AcB55 X A)F2 mice identified a novel, B6-derived, significant linkage on Chr. 3 (D3Mit109; LOD = 6.57) that was designated Char4, and that controls peak parasitemia. 69 This locus explains approximately 14% of the variance at peak parasitemia, and B6 alleles at this locus confer resistance to infection which is inherited in a recessive manner in both males and females (Figure 6b) . A second, suggestive linkage was mapped to Chr. 10 (D10Mit189; LOD = 2.53). Although this QTL was rather weak, and the percentage of variance explained by this locus/loci was only 6%, the additive effect of this locus on Char4 for controlling peak parasitemia in AcB55 was nevertheless clear. The Chr. 10 QTL segregates as dominant in females and co-dominant in males. 69 The size of the Chr. 3 congenic B6 segment in AcB55 that harbours Char4 is quite small at 6-10 cM (Figure 6b) , and contains several interesting candidates with respect to their known tissue or cell-specific expression or role in immune and/or inflammatory response. 69 These include (a) Lef1 (lymphoid enhancer binding factor 1), a transcription factor that regulates gene expression in Tlymphocytes and other lineages; 70, 71 (b) Cfi (complement component factor I, 66.6 cM), a regulatory serine protease that activates the cleavage of C3b/C4b, 72 a pathway known to be defective in A/J 73, 74 and responsible for the acute sensitivity of this line to Listeria infection; (c) the p105 subunit of NfB1, a signal transduction regulator known to be essential for B-cell function, and for nonspecific resistance to infections. 75 Other candidate genes regionally mapped to the area, include Csf1 (macrophage colony stimulating factor), 76, 77 and Vcam1 (vascular cell adhesion molecule).
78,79
Conclusion and future prospects
The mouse has proven to be an invaluable tool for the genetic analysis of susceptibility to malaria. However, the true value of genetic data obtained in the mouse cannot be fully evaluated without discussing some of the difficulties and limitations of the murine model of infection, in particular with respect to the assessment of the 'susceptibility' or 'resistance' phenotypes. For example, the route of infection (intravenous vs intraperitoneal) may affect synchronization of infection even amongst individual of identical genetic background in general, and in particular with respect to the length of the initial lag period and extent of blood stage replication of the parasite. Indeed, dissemination of an infectious inoculum introduced i.p. is likely to be less homogeneous than when introduced i.v., as it has to cross additional biological bar- riers to cause blood-stage infection. Therefore, the use of daily parasitemia as a quantitative trait for whole genome scan is difficult for i.p. infections of individuals from segregating backcross or F2 animals, as small genetic effects may be lost to experimental variation. Peak parasitemia can be used as an alternate indicator of parasitic replication and susceptibility to infection, even if it occurs at different days in different animals. Survival time can also be used to evaluate susceptibility, but it is subject to the same limitations discussed above and associated with difficulties in synchronizing the infections. In addition, death is generally not a simple trait, and the actual time of death can be influenced by multiple factors in addition to the extent of parasite replication, host inflammatory, immune and erythropoietic responses and general fitness traits. Furthermore, a strong sex effect has been observed in the mouse model of malaria, with females generally more resistant that males possibly because hormonal influence. 54, 80 This situation is also seen in humans, and may lead to false linkage to the X chromosome unless one uses sex-adjusted traits (parasitemia) in the quantitative analysis. 69 This can be alleviated altogether by using male or female mice only, and avoiding pooling the data. Finally, because individual inbred strains represent only a fraction of the genetic variation present in the wild, a
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Despite these limitations, at least four different QTLs playing a key role in regulating disease susceptibility have been identified in the mouse model of malaria infection which uses Plasmodium chabaudi. Of particular interest are the QTLs mapped on chromosomes 8 (Char2), and 9 (Char1), since they have been detected in different strain combinations, and using distinct sub-strains of P. chabaudi parasites. 53, 55 The validation of Char1/2 in different mouse strain combinations and with different parasites strongly suggests that the locus/loci underlying these genetic effects are likely to be robust, and possibly affecting an important host defense mechanism. It may be interesting to determine whether or not the corresponding synthenic chromosomal regions in humans are associated with susceptibility to malaria in different populations and in different endemic areas of disease worldwide. Likewise, the identification by positional cloning of the genes involved may reveal new important host response mechanisms against this infection, including possible new therapeutic targets for pharmacological intervention. However, it is important to point out that the QTLs identified for the Char1/2 loci are quite large, ranging in size from 15 to 30 cM. Therefore, such large segments could contain several hundred genes, making difficult the identification of the gene responsible by positional cloning, even after successful isolation of the gene effect in a congenic strain. Likewise, genetic effects mapped as unique QTLs may in fact result from additive effects of two or more independent but linked loci with each contributing a very small effect. The difficulties in going from QTLs to positional candidate genes, including the identification of quantitative trait nucleotides (QTNs) have been reviewed comprehensively by Flint and Mott (2001) . 81 The use of recombinant congenic (RC) strains to identify QTLs such as Char4 69 has several advantages over traditional mapping studies in segregating backcross and F2 mice. First and foremost, the size of the genetic interval underlying the QTL of interest is relatively small (5-10 cM), therefore reducing the number of candidate genes to be analyzed. Secondly, since a RC has already 87% of its genetic material from the background strain, pure congenic lines can be created in a relatively short period of time. This situation also minimizes the possibility of losing the expression of the QTL once it is isolated in a pure congenic line. For the same reasons, it is expected that gene expression profiles in different tissues and cell types of an individual RC strain may be very similar to those seen in the parental (background) strain, except for the genes involved in the phenotype of interest and/or located in the donor derived congenic segments (including the known QTL interval). This situation may facilitate the positional cloning of the genes involved and/or direct evaluation of their candidacy in transgenic animals containing large recombinant clones from the region.
In conclusion, despite obvious limitations, the mouse has proven to be a very useful and powerful tool for the genetic analysis of the complex trait of susceptibility to Markers shown were used to genotype mice of the F2 cross. Intermarker distances are based on the frequency of recombination in the cross, but their absolute positions along the chromosome are based on the mouse genome database. 62 The X axis of the graph represents the LOD-score values. Right panel presents the norms of reaction of the genotype at D3Mit109 according to the sex. Letter 'a', and 'b' represent alleles of A and B6 origins, respectively, and 'h' represents heterozygotes. Peak parasitemia is shown as a mean for each group. This figure has been adapted from Fortin et al. 69 malaria. Although the relevance of the mapped murine loci to the human situation remains to be investigated, they provide a rational entry point for association studies in endemic areas of human malaria. They may also provide new insights into the pathophysiology of this complex disease, a particularly important alternative to the mounting problem of drug resistance in the Plasmodium parasite.
